Jundishapur Journal of Microbiology

Published by: Kowsar

Extraction and Biological Evaluation of the Membrane Vesicles of Mycobacterium tuberculosis (CRBIP7.11) as Adjuvant and Vaccine Candidate

Shirin Sam Daliri 1 , Hossein Samadi Kafil 2 , Mohammad Aghazadeh 1 , Abolfazl Fateh 3 , 4 , Mehdi Yousefi 1 and Seyed Davar Siadat 3 , 4 , *
Authors Information
1 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
4 Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2017, 10 (3); e39953
  • Published Online: January 25, 2017
  • Article Type: Research Article
  • Received: June 29, 2016
  • Revised: December 16, 2016
  • Accepted: January 15, 2017
  • DOI: 10.5812/jjm.39953

To Cite: Sam Daliri S, Samadi Kafil H, Aghazadeh M, Fateh A, Yousefi M, et al. Extraction and Biological Evaluation of the Membrane Vesicles of Mycobacterium tuberculosis (CRBIP7.11) as Adjuvant and Vaccine Candidate, Jundishapur J Microbiol. 2017 ; 10(3):e39953. doi: 10.5812/jjm.39953.

Abstract
Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Bialvaei AZ, Asgharzadeh M, Aghazadeh M, Nourazarian M, Kafil HS. Challenges of Tuberculosis in Iran. Jundishapur J Microbiol . 2017; 10(2)[DOI]
  • 2. Global Tuberculosis Control. WHO Report. 2013;
  • 3. Asgharzadeh M, Samadi Kafil H, Khakpour M. Comparison of mycobacterial interspersed repetitive unit-variable number tandem repeat and IS6110-RFLP methods in identifying epidemiological links in patients with tuberculosis in Northwest of Iran. Ann Microbiol. 2008; 58(2): 333-9[DOI]
  • 4. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995; 346(8986): 1339-45[PubMed]
  • 5. Verma I, Pandey R, Khuller GK. Liposomes as adjuvant for anti-mycobacterial vaccine development. Indian J Exp Biol. 2004; 42(10): 949-54[PubMed]
  • 6. Audibert FM, Lise LD. Adjuvants: current status, clinical perspectives and future prospects. Immunol Today. 1993; 14(6): 281-4[DOI][PubMed]
  • 7. Marsollier L, Brodin P, Jackson M, Kordulakova J, Tafelmeyer P, Carbonnelle E, et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog. 2007; 3(5)[DOI][PubMed]
  • 8. Prados-Rosales R, Brown L, Casadevall A, Montalvo-Quiros S, Luque-Garcia JL. Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria. MethodsX. 2014; 1: 124-9[DOI][PubMed]
  • 9. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005; 19(22): 2645-55[DOI][PubMed]
  • 10. Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest. 2011; 121(4): 1471-83[DOI][PubMed]
  • 11. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9(8): 581-93[DOI][PubMed]
  • 12. Hanna BA, Walters SB, Bonk SJ, Tick LJ. Recovery of mycobacteria from blood in mycobacteria growth indicator tube and Lowenstein-Jensen slant after lysis-centrifugation. J Clin Microbiol. 1995; 33(12): 3315-6[PubMed]
  • 13. Asgharzadeh M, Samadi Kafil H, Pourostadi M. Limited transmission of multidrug-resistant tuberculosis in East Azarbaijan, Iran. Beni-Suef Univ J Basic Appl Sci. 2014; 3(4): 254-9[DOI]
  • 14. Claassen I, Meylis J, van der Ley P, Peeters C, Brons H, Robert J, et al. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine. 1996; 14(10): 1001-8[PubMed]
  • 15. Bloom BR, Fine PEM. Tuberculosis. 1994; : 531-57
  • 16. Asgharzadeh M, Kafil HS, Roudsary AA, Hanifi GR. Tuberculosis transmission in Northwest of Iran: using MIRU-VNTR, ETR-VNTR and IS6110-RFLP methods. Infect Genet Evol. 2011; 11(1): 124-31[DOI][PubMed]
  • 17. Davenne T, McShane H. Why don't we have an effective tuberculosis vaccine yet? Expert Rev Vaccines. 2016; 15(8): 1009-13[DOI][PubMed]
  • 18. Friedman S, Rotstein I, Shar-Lev S. Bypassing gutta-percha root fillings with an automated device. J Endod. 1989; 15(9): 432-7[DOI][PubMed]
  • 19. Athman JJ, Wang Y, McDonald DJ, Boom WH, Harding CV, Wearsch PA. Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages. J Immunol. 2015; 195(3): 1044-53[DOI][PubMed]
  • 20. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 2010; 8(4): 296-307[DOI][PubMed]
  • 21. Fratti RA, Chua J, Vergne I, Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A. 2003; 100(9): 5437-42[DOI][PubMed]
  • 22. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010; 10(3): 170-81[DOI][PubMed]
  • 23. Rath P, Huang C, Wang T, Wang T, Li H, Prados-Rosales R, et al. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2013; 110(49)-7[DOI][PubMed]
  • 24. Prados-Rosales R, Weinrick BC, Pique DG, Jacobs WJ, Casadevall A, Rodriguez GM. Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J Bacteriol. 2014; 196(6): 1250-6[DOI][PubMed]
  • 25. Acevedo R, Fernandez S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, et al. Bacterial outer membrane vesicles and vaccine applications. Front Immunol. 2014; 5: 121[DOI][PubMed]
  • 26. Keenan JI, Rijpkema SG, Durrani Z, Roake JA. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. FEMS Immunol Med Microbiol. 2003; 36(3): 199-205[PubMed]
  • 27. Nokleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. Vaccine. 2007; 25(16): 3080-4[DOI][PubMed]
  • 28. Schild S, Nelson EJ, Camilli A. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun. 2008; 76(10): 4554-63[DOI][PubMed]
  • 29. Luijkx T, van Dijken H, van Els C, van den Dobbelsteen G. Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine. Vaccine. 2006; 24(10): 1569-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments